Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
Abstract Early access programs (EAPs) generally refer to patient access to medicines/indications before marketing authorization, possibly extended to price and reimbursement approval. These programs include compassionate use, which is usually covered by pharmaceutical companies, and EAPs reimbursed...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2023-05-01
|
| Серія: | Journal of Pharmaceutical Policy and Practice |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s40545-023-00570-z |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|